For the quarter ending 2026-03-31, CGTX has $36,140K in assets. $6,229K in debts. $31,130K in cash and cash equivalents.
| Balance Sheets | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Cash and cash equivalents | 31,130 | 36,810 | 39,334 | 10,743 |
| Grant receivables | 3,657 | 9,923 | 1,900 | 6,285 |
| Prepaid expenses and other current assets | 932 | 1,068 | 1,160 | 1,207 |
| Restricted cash equivalents | 95 | 190 | 489 | 814 |
| Total current assets | 35,814 | 47,991 | 42,883 | 19,049 |
| Property and equipment, net | 77 | 93 | 159 | 174 |
| Right-of-use assets, operating leases | 249 | 306 | 353 | 399 |
| Total assets | 36,140 | 48,390 | 43,395 | 19,622 |
| Accounts payable | 3,850 | 1,119 | 827 | 771 |
| Accrued expenses | 1,694 | 11,995 | 3,923 | 9,372 |
| Deferred grant income, current | 220 | 367 | 1,736 | 1,982 |
| Operating lease liabilities, current | 95 | 136 | 168 | 198 |
| Other current liabilities | 194 | 307 | - | 41 |
| Total current liabilities | 6,053 | 13,924 | 6,654 | 12,364 |
| Operating lease liabilities, non-current | 176 | 195 | 212 | 229 |
| Total liabilities | 6,229 | 14,119 | 6,866 | 12,593 |
| Common stock, 0.001 par value, 250,000,000 shares authorized 89,353,773 and 88,268,078 shares issued and outstanding at march 31, 2026 and december 31, 2025, respectively | 90 | 90 | 88 | 65 |
| Additional paid-in capital | 233,038 | 232,828 | 231,745 | 197,338 |
| Accumulated deficit | -203,217 | -198,647 | -195,304 | -190,374 |
| Total stockholders' equity | 29,911 | 34,271 | 36,529 | 7,029 |
| Total liabilities and stockholders' equity | 36,140 | 48,390 | 43,395 | 19,622 |
COGNITION THERAPEUTICS INC (CGTX)
COGNITION THERAPEUTICS INC (CGTX)